ArticleBirth defects research2026
Congenital Heart Disease Associated With Genetic Syndromes and Extracardiac Anomalies: A Six-Year Epidemiological Study in a Brazilian Referral Center.
Article in Birth defects research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCongenital heart diseases (CHDs) are structural and/or functional abnormalities of the heart that arise during embryonic cardiovascular development. They are the most common type of congenital defect and represent a major cause of neonatal morbidity and mortality, particularly when associated with genetic syndromes or other congenital anomalies. This study aims to analyze the clinical and epidemiological profile of CHD in newborns at a high fetal-risk maternity hospital in Rio de Janeiro from 2018 to 2023, describing the types of CHD, associated anomalies and genetic syndromes, maternal risk factors, and neonatal outcomes.
methodsThis is a descriptive, retrospective study using the database of the Latin American Collaborative Study of Congenital Malformations (ECLAMC) at Instituto Fernandes Figueira/Fiocruz (IFF/Fiocruz). Newborns with a confirmed diagnosis of CHD, born at IFF between January 2018 and December 2023 and properly registered in the ECLAMC program were included.
resultsAmong 5647 births, 225 newborns with CHD were identified and analyzed, corresponding to a prevalence of approximately 4%. The most frequent CHD was ventricular septal defect (VSD), present in 68 cases, followed by atrioventricular septal defect (AVSD) in 41 cases and coarctation of the aorta (CoA) in 27. Complex cardiopathies predominated, representing 60% of cases. Most diagnoses were established prenatally (93.3%), with a fetal echocardiogram accuracy of 78.5%. Associated congenital anomalies were identified in 64% of cases, predominantly affecting the gastrointestinal tract, central nervous system, and genitourinary tract. Genetic syndromes were confirmed in 95 patients (42.2%), with a predominance of Down syndrome (35), followed by Edwards syndrome (29) and Patau syndrome (10). The rate of hospital discharge alive was 53.3% in patients with isolated CHD, compared to 29% in those with associated syndromes or anomalies.
conclusionsIFF presents a highly complex patient profile, with a high prevalence of CHD associated with genetic syndromes and extracardiac anomalies, reflecting its role as a tertiary referral center. The presence of associated anomalies and syndromes negatively impacted neonatal prognosis, reinforcing the importance of prenatal diagnosis and specialized multidisciplinary care in the management of these conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.